Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 125706, 9 pages
http://dx.doi.org/10.1155/2014/125706
Clinical Study

The Incidence and Predictors of Thromboembolic Events in Patients with Lung Cancer

1Department of Respiratory Diseases and TB, Faculty of Medicine, Masaryk University and University Hospital, Brno, Czech Republic
2Institute of Biostatistics and Analyses, Faculty of Medicine and Faculty of Science, Masaryk University, Brno, Czech Republic

Received 30 August 2013; Accepted 30 October 2013; Published 20 January 2014

Academic Editors: A. Niemierko and C. A. Perez

Copyright © 2014 Bohdan Kadlec et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [8 citations]

The following is the list of published articles that have cited the current article.

  • Ahmed M. E. Abdalla, Lin Xiao, Chenxi Ouyang, and Guang Yang, “Engineered nanoparticles: thrombotic events in cancer,” Nanoscale, vol. 6, no. 23, pp. 14141–14152, 2014. View at Publisher · View at Google Scholar
  • Carolina Vitale, Maria D'Amato, Paolo Calabrò, Anna Agnese Stanziola, Mauro Mormile, and Antonio Molino, “Venous thromboembolism and lung cancer: a review.,” Multidisciplinary respiratory medicine, vol. 10, no. 1, pp. 28, 2015. View at Publisher · View at Google Scholar
  • Alex J Walker, David R Baldwin, Tim R Card, Helen A Powell, Richard B Hubbard, and Matthew J Grainge, “Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data,” British Journal of Cancer, 2016. View at Publisher · View at Google Scholar
  • Marliese Alexander, and Kate Burbury, “A systematic review of biomarkers for the prediction of thromboembolism in lung cancer — Results, practical issues and proposed strategies for future risk prediction models,” Thrombosis Research, vol. 148, pp. 63–69, 2016. View at Publisher · View at Google Scholar
  • Tomasz Urbanek, Janina Markowska, Rodryg Ramlau, Stefan Sajdak, Krzysztof Ziaja, Wojciech Sydor, Piotr Wysocki, Beata Begier-Krasińska, Piotr Ładziński, Piotr Rutkowski, Damian Ziaja, Zbigniew Krasiński, Maciej Kostrubiec, Artur Antoniewicz, Wojciech Dyszkiewicz, and Jan Kulig, “Venous thromboembolism prophylaxis in cancer patients — guidelines focus on surgical patients,” Acta Angiologica, vol. 22, no. 3, pp. 71–102, 2016. View at Publisher · View at Google Scholar
  • Wu, Dai, Zhang, He, Xia, Zhang, Li, Zhao, and Xia, “Risk factors associated with mortality from vascular thromboembolic events in patients diagnosed with non-small cell lung cancer: A population-based analysis,” Qjm, vol. 110, no. 12, pp. 807–813, 2017. View at Publisher · View at Google Scholar
  • Claire K. S. Meikle, Clare A. Kelly, Priyanka Garg, Leah M. Wuescher, Ramadan A. Ali, and Randall G. Worth, “Cancer and Thrombosis: The Platelet Perspective,” Frontiers in Cell and Developmental Biology, vol. 4, 2017. View at Publisher · View at Google Scholar
  • Kelvin Young, Luis Paz-Ares, Nick Thatcher, David R. Spigel, Javad Shahidi, Victoria Soldatenkova, Gerrit Grau, Raffael Kurek, and Frances A. Shepherd, “Venous thromboembolism with EGFR monoclonal antibody necitumumab in stage IV non-small cell lung cancer: A retrospective cohort analysis,” Thrombosis Research, 2018. View at Publisher · View at Google Scholar